C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
12/2004
12/01/2004	EP1236726B1 Triazaspiro 5.5]undecane derivatives and drugs containing the same as the active ingredient
12/01/2004	EP1181280B1 Substituted benzoyl ketones, methods for producing them and their use as herbicides
12/01/2004	EP0977745B1 Thioaryl sulfonamide hydroxamic acid compounds
12/01/2004	CN1551885A Cyclic indole and heteroindole derivatives, the production and use thereof as medicaments
12/01/2004	CN1550499A Preparation for sulfamoyl compounds
12/01/2004	CN1177850C Camptothecin analogs and methods of preparation thereof
12/01/2004	CN1177844C Cyclopropanes as CGRP antagonists, medicaments contg. said compounds and method for production thereof
12/01/2004	CN1177835C Substituted benzoylcyclohexandiones
12/01/2004	CN1177831C New benzimidazolone-benzoxazolone-, or benzothiazoloe derivatives as ion channel modulating agents
11/2004
11/30/2004	US6825350 Administering dosage of immunology response moderator
11/30/2004	US6825347 Uronium and immonium salts for peptide coupling
11/30/2004	US6825212 1-(aminoalkyl)-3-sulfonylazaindoles as 5-hydroxytryptamine-6 ligands
11/30/2004	US6825210 5,10-dihydrobenzo(b)(1,8)naphthyridine compounds, n-oxides; 3,7-dichloro-5-isopropoxymethyl-5-trifluoromethyl-5,10 -dihydrobenzo(b)(1,8)naphthyridine for example; combination therapy
11/30/2004	US6825209 Compounds having unique CB1 receptor binding selectivity and methods for their production and use
11/30/2004	US6825201 Indole, azaindole and related heterocyclic amidopiperazine derivatives
11/30/2004	US6825199 7-Substituted quinazolin-2,4-diones useful as antibacterial agents
11/30/2004	US6825197 Cyclic GMP-specific phosphodiesterase inhibitors
11/30/2004	US6825191 Benzodiazepine derivatives
11/30/2004	US6825184 For use as anti-inflammatory agents
11/30/2004	US6825180 Cytokine intracellular signaling inhibitors; antiinflammatory agents
11/30/2004	CA2322540C Process for preparing a protected 4-aminomethyl-pyrrolidin-3-one
11/25/2004	WO2004101573A1 Synthesis of substituted heterocyclic compounds
11/25/2004	WO2004101566A1 Novel intermediate for the preparation of therapeutically active imidazopyridines
11/25/2004	WO2004101565A2 Jnk inhibitors
11/25/2004	WO2004101564A1 Pyrimidine derivatives possessing cell-cycle inhibitory activity
11/25/2004	WO2004101563A1 AZAINDOLE-DERIVATIVES AS FACTOR Xa INHIBITORS
11/25/2004	WO2004101558A1 2-imidazo-benzothiazoles as adenosine receptor ligands
11/25/2004	WO2004101553A1 BENZIMIDAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS
11/25/2004	WO2004101517A1 Carbazole derivative, organic semiconductor device, light-emitting device, and electronic device
11/25/2004	WO2004101512A2 Naphthyridine integrase inhibitors
11/25/2004	WO2004100946A1 1- (2h-pyrazol -3-yl) -3yl) {4-`1- (benzoyl) -piperidin-4-ylmethyl!-phenyl}-urea derivatives and related compounds as inhbitors of p38 kinase and/or tnf inhibitors for the treatment of imflammations
11/25/2004	WO2004100891A2 Cytotoxic indeno and isoindoloisoquinolones
11/25/2004	WO2004091627A3 Heterocyclic substituted 1,4-dihydro-4-oxo-1,8-naphthpyridine analogs
11/25/2004	WO2004087703A8 Process for the preparation of n,n,6-trimethyl-2-(4-methylphenyl)-imidazo[1,2-a]pyridine-3-acetamide
11/25/2004	WO2004083174A3 Sulfonyl-amidino containing and tetrahydropyrimidino containing compounds as factor xa inhibitors
11/25/2004	WO2004034972A3 Compounds, compositions, and methods
11/25/2004	WO2004021984A3 Heterocyclic aromatic compounds useful as growth hormone secretagogues
11/25/2004	WO2004007407A3 Fluorous tagging and scavenging reactants and methods of synthesis and use thereof
11/25/2004	US20040235924 antidepressants; anxiolytic agents; eating disorders; post-traumatic stress disorders; headaches;drug addition; antiinflammatory agents
11/25/2004	US20040235914 Acyclic, aromatic, heteroaromatic and cyclic ring containing amido-derivatives, useful as antibacterial agent; inhibition of formation of biofilms in personal hygiene articles, toileteries, cosmetics and in industrial settings like ship hulls, food processing systems, oil recovery or paper making plants
11/25/2004	US20040235886 Gyrase inhibitors and uses thereof
11/25/2004	US20040235883 Alkyl-substituted imidazopyridines for the treatment of gastrointestinal disorders
11/25/2004	US20040235882 compounds such as (8R,9R)-2,3-Dimethyl-9-phenyl-8-pivaloyloxy-7,8,9,10-tetrahydroimidazo[1.2-h][1.7]naphthyridin-7-one, used as antisecretory agents
11/25/2004	US20040235871 A hexahydro-1,5,6,8-tetraaza-acenaphthylene or -1,3,4-triazaphenalene derivatives; treatment of depression and anxiety; inflammatory bowel disease; treatment of conditions mediated by corticotropin-releasing factor
11/25/2004	US20040235870 Protein kinase inhibitors
11/25/2004	US20040235869 For therapy of subject infected with a retrovirus
11/25/2004	US20040235867 Drugs used for signal transduction modulation, and for prophylaxis of angiogenesis, cancers, tumors, atherosclerosis, vision disorders and inflammatory diseases in mammals
11/25/2004	US20040235864 Jun kinase inhibitors
11/25/2004	US20040235863 As stimulators for soluble guanylate cyclase and to their use as agents in the therapy of cardiovascular diseases, hypertonicity, thrombo-embolic diseases and ischemia, sexual dysfunction or inflammations and for the treatment of diseases of the central nervous system
11/25/2004	US20040235848 Phenylalanine derivatives
11/25/2004	US20040235841 For therapy and prophylaxis of diseases and disorders associated with cyclin-dependent kinases (CDKs) activity
11/25/2004	US20040235839 Beta-carbolines useful for treating inflammatory disease
11/25/2004	US20040235830 Substituted cyclohexane derivatives and the use thereof in medicaments for treating cardiovascular diseases
11/25/2004	US20040235823 Administering compounds such as N-(2-pyridinylmethyl)-N'-(6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-yl)-1,4-benzenedimethanamine for therapy of disease mediated by a chemokine receptor
11/25/2004	US20040235818 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
11/25/2004	US20040235815 Vanadium compounds for treating cancer
11/25/2004	US20040235814 Administering compounds such as 1-[1-methylene-4-(bromo-methylene)phenylene]-4,8,11-tris(diethoxyphosphoryl-1,4,8,11-tetraazacyclotetra-decane to modulate a chemokine receptor
11/25/2004	US20040235753 Oxytocin agonists
11/25/2004	US20040235752 3-fluoro-pyrrolidines as antidiabetic agents
11/25/2004	US20040234809 a functional layer ( emissive layer, electron transport layer, hole transport, electron blocking, a hole blocking) is sandwiched between an anode and a cathode
11/25/2004	DE10308351A1 1,3-substituierte Cycloalkylderivate mit sauren, meist heterocyclischen Gruppen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel 1,3-substituted cycloalkyl derivatives having acidic, mostly heterocyclic groups, processes for their preparation and their use as medicaments
11/25/2004	CA2526084A1 Azaindole-derivatives as factor xa inhibitors
11/25/2004	CA2526065A1 Benzimidazole-derivatives as factor xa inhibitors
11/25/2004	CA2525099A1 Cytotoxic indeno and isoindoloisoquinolones
11/25/2004	CA2525038A1 Novel intermediate for the preparation of therapeutically active imidazopyridines
11/25/2004	CA2524706A1 Synthesis of substituted heterocyclic compounds
11/25/2004	CA2523959A1 2-imidazo-benzothiazoles as adenosine receptor ligands
11/24/2004	EP1479681A1 IMIDAZO(1,2-a)PYRIDINE DERIVATIVE
11/24/2004	EP1479680A1 Azaindole derivatives as Factor Xa inhibitors
11/24/2004	EP1479676A1 Benzimidazole-derivatives as factor xa inhibitors
11/24/2004	EP1479397A1 2,4,6-triamino-1,3,5-triazine derivative
11/24/2004	EP1478645A2 Quinolinone derivatives for treating cell proliferation related disorders
11/24/2004	EP1478629A1 N-aryl-2-oxazolidinone-5-carboxamides and their derivatives and their use as antibacterials
11/24/2004	EP1478628A1 2-amino-4-bicyclyl amino-6h-1.3.5-triazines, method for the production and use thereof as herbicides and plant growth regulators
11/24/2004	EP1478624A1 Chemical compounds
11/24/2004	EP1478364A2 Selective antibacterial agents
11/24/2004	EP1478357A2 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents
11/24/2004	EP1411949A4 8/17 heterocyclic compounds and uses thereof as d-alanyl-d-alanine ligase inhibitors
11/24/2004	EP1185536B1 Hemisynthetic method and intermediates thereof
11/24/2004	EP1180030B1 Antibacterial compounds
11/24/2004	CN1549816A N-aroyl cyclic amine derivatives as orexin receptor antagonists
11/24/2004	CN1549812A Pyrazole compounds useful as protein kinase inhibitors.
11/24/2004	CN1176921C Semi-hydrochloride of 8-cyan-1-cyclopropyl-7-(1S-2,8-diazabicyclo [4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid
11/23/2004	US6822098 Carbocyclic carbo, oxo amines such as n-heptyl-3-methyl-4-oxo -1,4-dihydroquinoline-2-carboxamide, used for prophylaxis of gastrointerstinal disorders
11/23/2004	US6822097 Compounds and methods of uses
11/23/2004	US6821984 Ring fused pyrazole derivatives as CRF antagonists
11/23/2004	US6821967 Amines such as 9-(4-(4-(benzothiazol-2-yl)-piperazin-1-yl)-butyl)-9h-fluorene-9-carboxylic acid (2,2,2-trifluoroethyl) amide, used as microsomal triglyceride transfer protein antagonists, to prevent atherosclerosis or hyperlipemia
11/23/2004	US6821962 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and /or p56lck tyrosine kinases
11/23/2004	CA2332087C Aryl substituted azabenzimidazoles and their use in the treatment of hiv and aids related diseases
11/23/2004	CA2171446C Pseudo- and non-peptide bradykinin receptor antagonists
11/23/2004	CA2111662C Biphenyl derivatives, their preparation and their use for the treatment of hypertension and cardiac disease
11/18/2004	WO2004099339A1 Organic electroluminescent device and platinum compound
11/18/2004	WO2004099209A1 Fused pyrimidine derivatives with crf activity
11/18/2004	WO2004099205A1 Azaindole compounds as kinase inhibitors
11/18/2004	WO2004099204A1 Imidazo and thiazolopyridines as jak3 kinase inhibitors
11/18/2004	WO2004099203A1 Imidazopyridine intermediates
11/18/2004	WO2004099189A1 Methyl indoles and methyl pyrrolopyridines as alph-1 adrenergic agonists
11/18/2004	WO2004099177A1 Substituted-1-phthalazinamines as vr-1 antagonists
11/18/2004	WO2004099176A1 Derivatives of piperidinyl- and piperazinyl-alkyl carbamates, preparation methods thereof and application of same in therapeutics
11/18/2004	WO2004099168A2 Substituted carboxylic acids

1 ... 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 ... 646